AFP and hepatocellular carcinoma: Conversely, when AFP and PIVKA-II were combined in an algorithm, GAAD detected six additional early-stage and three additional late-stage HCC cases that were missed by GALAD (μTASWAKO), while displaying the same specificity for the CLD controls (Table 2).